Matheke, Cynthia A.

Sebastian Martinek worked at Pennie & Edmonds from 2001 through 2003 where he handled patent prosecution in the biotechnology, pharmaceutical, and chemical practice areas and handled opinion work for biotechnology matters as well.

While studying for his doctorate, Sebastian conceived, developed, and implemented a new double-stranded RNA-based technique to overcome limitations of conventional genetic approaches; worked on the characterization of the tumor suppressor p53; uncovered a new function of Glycogen Synthase Kinase-3 (GSK-3) related to development and metabolism; cloned, sequenced, and characterized a new gene involved in RNA processing; assisted in exploring the function of a new component of the STAT signaling pathway; and launched a project to explore the interaction between cell adhesion and intracellular signaling events.